Scientists at the University of Newcastle have developed a new technique which makes use of UV light to target cancer tumours.
The cancer treatment involves the cloaking of antibodies which can subsequently be activated by UV-A light and then targeted at a specific area of the body through the shining of a probe at a designated part.
As a result, antibodies can be activated to attack tumours while leaving healthy tissue unharmed.
According to Newcastle University researcher Professor Colin Self, the treatment is "the equivalent of ultra-specific magic bullets".
The research, published in the journal ChemMedChem, has been praised by Josephine Querido, the senior science information officer for Cancer Research UK.
"Developing treatments that attack cancer cells but leave healthy tissue unharmed is the holy grail of cancer research," she said.
"Although at a very early stage, this new approach has potential, and we await the outcome of further research with interest."